Percutaneous left ventricular assist device support during ablation of ventricular tachycardia: A meta‐analysis of current evidence.
Introduction: Catheter ablation of ventricular tachycardia (VT) can be an effective therapy to reduce VT burden, but often it is limited by the potential for hemodynamic instability. Percutaneous left ventricular assist devices (pLVADs) have been used to maintain hemodynamic support during VT ablati...
| Publicado en: | Journal of Cardiovascular Electrophysiology Vol. 30; no. 6; pp. 886 - 896 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | research systematic review tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
Jun2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=137145520&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 137145520 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10453873 GSB jtl: Journal of Cardiovascular Electrophysiology issn: 10453873 maglogo: Y pubinfo: dt: Jun2019 vid: 30 iid: 6 pid: 480 pub: Wiley-Blackwell place: Malden, Massachusetts artinfo: ui: 137145520 137145520 137145520 10.1111/jce.13907 137145520 ppf: 886 ppct: 10 formats: fmt: – @attributes: type: T – @attributes: type: C – @attributes: type: P tig: atl: Percutaneous left ventricular assist device support during ablation of ventricular tachycardia: A meta‐analysis of current evidence. aug: au: Luni, Faraz Khan Zungsontiporn, Nath Farid, Talha Malik, Sonia Ali Khan, Sobia Daniels, James Wu, Richard Link, Mark S. Joglar, Jose A. affil: Department of Cardiology, UT Southwestern Medical Center, Dallas Texas sug: subj: Heart Assist Devices Methods Catheter Ablation Methods Tachycardia, Ventricular Surgery Hemodynamics Human Meta Analysis Systematic Review PubMed Tachycardia, Ventricular Mortality Treatment Duration Treatment Outcomes Catheter Ablation Adverse Effects Risk Assessment ab: Introduction: Catheter ablation of ventricular tachycardia (VT) can be an effective therapy to reduce VT burden, but often it is limited by the potential for hemodynamic instability. Percutaneous left ventricular assist devices (pLVADs) have been used to maintain hemodynamic support during VT ablation but the evidence regarding its clinical impact has been inconclusive. Methods and Results: We sought to assess the clinical impact of pLVAD when used in VT ablation by conducting a meta‐analysis of the current evidence. We searched Pubmed and found nine observational studies that compared clinical outcomes of VT ablation in patients with pLVAD support to controls with no pLVAD support. The pooled data did not show a significant difference in mortality between both groups, nor a difference in acute procedural success or in recurrence of VT. There was also no difference in the number of patients receiving a cardiac transplant or being enrolled in the transplant list. Although there was no difference in the ablation time between the groups, patients in the pLVAD group had a longer total procedural time and more procedure‐related adverse effects. Conclusion: This meta‐analysis did not show clinical benefits from using pLVAD support during VT ablation, whereas it was associated with longer procedure times and more complications. This study was, however, limited by the observational nature of the data. In view of these data, the risk and benefit of pLVAD support during VT ablation should be considered on an individual basis. pubtype: Academic Journal doctype: meta analysis research systematic review tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|